Patents Assigned to Ontogen
  • Modulators of protein tyrosine phosphatases (PTPases)
    Patent number: 6169087
    Abstract: The present invention provides novel compounds of Formula 1 or Formula 2 and compositions thereof, methods of their use, and methods of their manufacture, wherein X, Y, Z, W, R1, R2 and R3 are defined more fully in the description. These compounds are useful in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance, obesity, and a number of other diseases.
    Type: Grant
    Filed: September 21, 1998
    Date of Patent: January 2, 2001
    Assignees: Novo Nordisk A/S, Ontogen
    Inventors: Henrik Sune Andersen, Sven Branner, Claus Bekker Jeppesen, Niels Peter Hundahl Moeller, Adnan M. M. Mjalli, Sepehr Sarshar